With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.
With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.
Guidepoint Qsight’s healthcare facilities purchasing dataset captures trends in multiple segments within the MedTech space. We break down insights on these segments and the top manufacturers in the space.
With Abbott announcing the availability of its Amplatzer Steerable Delivery Sheath, Guidepoint Qsight took a closer look at the left atrial appendage closure market...
Qsight’s medical device purchasing dataset captures trends in several markets, including the orthopedics market. We took a closer look at top manufactures in the orthopedics segment to figure out which players were contributing to and detracting from overall growth of the market. Orthopedic procedures, largely elective, are more at risk to cancellations during the COVID-19…
After the launch of Penumbra’s new product, the RED 72 catheter, we took a look at its impact and other historical trends in the ischemic stroke market. Qsight’s healthcare facility purchasing dataset shows the immediate impact of recalls and new product launches in the ischemic stroke market. After the recall of the Jet 7…
Guidepoint Qsight captured insights into the overall U.S. Orthopedics Knee market, identifying tremendous double-digit growth in Q2 2021, up 13.5% from Q1 2021. Although Zimmer Biomet reported sequential growth (+11.6%) for the U.S. Orthopedic Knee market, Qsight data indicates a loss of share in Q2 2021, marking the second consecutive quarter that Zimmer Knee has…
Guidepoint Qsight’s medical device market-level dataset has captured trends in multiple MedTech market segments. Following the sharp drop at the beginning of the COVID-19 pandemic, U.S. medical device purchasing spend rebounded quickly in July 2020 back to pre-COVID-19 levels for all five market segments captured in our dataset. Segments most subject to elective procedures experienced…
